Skip to main content
PMC home page
Gut logoLink to Gut
. 2001 Dec;49(6):866–872. doi: 10.1136/gut.49.6.866

Portal hypertensive gastropathy and gastric antral vascular ectasia (GAVE) syndrome

K BURAK 1, S LEE 1, P BECK 1
PMCID: PMC1728555  PMID: 11709525

Full Text

The Full Text of this article is available as a PDF (197.8 KB).

Figure 1  .

Figure 1  

Open in a new tab

Endoscopic findings of portal hypertensive gastropathy (PHG) and gastric antral vascular ectasia (GAVE) syndrome. PHG: (A, B) with mosaic pattern and cherry red spots. GAVE syndrome: (C) classic or linear pattern, (D) diffuse pattern of involvement.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Agnihotri N., Kaur S., Dilawari J. B., Bhusnurmath S. R., Kaur U. Diminution in parietal cell number in experimental portal hypertensive gastropathy. Dig Dis Sci. 1997 Feb;42(2):431–439. doi: 10.1023/a:1018898826201. [DOI] [PubMed] [Google Scholar]
  2. Amarapurkar D. N., Dhawan P. S., Chopra K., Shankaran K., Kalro R. H. Stomach in portal hypertension. J Assoc Physicians India. 1993 Oct;41(10):638–640. [PubMed] [Google Scholar]
  3. Arakawa T., Satoh H., Fukuda T., Nakamura H., Kobayashi K. Endogenous prostaglandin E2 in gastric mucosa of patients with alcoholic cirrhosis and portal hypertension. Gastroenterology. 1987 Jul;93(1):135–140. doi: 10.1016/0016-5085(87)90325-8. [DOI] [PubMed] [Google Scholar]
  4. Arakawa T., Tarnawski A., Mach T., Kobayashi K., Sarfeh I. J. Impaired generation of prostaglandins from isolated gastric surface epithelial cells in portal hypertensive rats. Prostaglandins. 1990 Oct;40(4):373–382. doi: 10.1016/0090-6980(90)90102-2. [DOI] [PubMed] [Google Scholar]
  5. Bahnacy A., Kupcsulik P., Elés Z. S., Jàray B., Flautner L. Helicobacter pylori and congestive gastropathy. Z Gastroenterol. 1997 Feb;35(2):109–112. [PubMed] [Google Scholar]
  6. Balan K. K., Jones A. T., Roberts N. B., Pearson J. P., Critchley M., Jenkins S. A. The effects of Helicobacter pylori colonization on gastric function and the incidence of portal hypertensive gastropathy in patients with cirrhosis of the liver. Am J Gastroenterol. 1996 Jul;91(7):1400–1406. [PubMed] [Google Scholar]
  7. Barbara G., De Giorgio R., Salvioli B., Stanghellini V., Corinaldesi R. Unsuccessful octreotide treatment of the watermelon stomach. J Clin Gastroenterol. 1998 Jun;26(4):345–346. doi: 10.1097/00004836-199806000-00029. [DOI] [PubMed] [Google Scholar]
  8. Beck P. L., Lee S. S., McKnight G. W., Wallace J. L. Characterization of spontaneous and ethanol-induced gastric damage in cirrhotic rats. Gastroenterology. 1992 Sep;103(3):1048–1055. doi: 10.1016/0016-5085(92)90042-w. [DOI] [PubMed] [Google Scholar]
  9. Beck P. L., McKnight G. W., Kelly J. K., Wallace J. L., Lee S. S. Hepatic and gastric cytoprotective effects of long-term prostaglandin E1 administration in cirrhotic rats. Gastroenterology. 1993 Nov;105(5):1483–1489. doi: 10.1016/0016-5085(93)90155-6. [DOI] [PubMed] [Google Scholar]
  10. Beck P. L., McKnight W., Lee S. S., Wallace J. L. Prostaglandin modulation of the gastric vasculature and mucosal integrity in cirrhotic rats. Am J Physiol. 1993 Sep;265(3 Pt 1):G453–G458. doi: 10.1152/ajpgi.1993.265.3.G453. [DOI] [PubMed] [Google Scholar]
  11. Bernstein D. E., Phillips R. S. Portal hypertensive gastropathy. Gastrointest Endosc Clin N Am. 1996 Oct;6(4):697–708. [PubMed] [Google Scholar]
  12. Bjorkman D. J., Buchi K. N. Endoscopic laser therapy of the watermelon stomach. Lasers Surg Med. 1992;12(5):478–481. doi: 10.1002/lsm.1900120504. [DOI] [PubMed] [Google Scholar]
  13. Calès P., Voigt J. J., Payen J. L., Bloom E., Berg P., Vinel J. P., Pradère B., Broussy P., Pascal J. P. Diffuse vascular ectasia of the antrum, duodenum, and jejunum in a patient with nodular regenerative hyperplasia. Lack of response to portosystemic shunt or gastrectomy. Gut. 1993 Apr;34(4):558–561. doi: 10.1136/gut.34.4.558. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Carpinelli L., Primignani M., Preatoni P., Angeli P., Battaglia G., Beretta L., Bortoli A., Capria A., Cestari R., Cosentino F. Portal hypertensive gastropathy: reproducibility of a classification, prevalence of elementary lesions, sensitivity and specificity in the diagnosis of cirrhosis of the liver. A NIEC multicentre study. New Italian Endoscopic Club. Ital J Gastroenterol Hepatol. 1997 Dec;29(6):533–540. [PubMed] [Google Scholar]
  15. Chan C. C., Lee F. Y., Wang S. S., Chang F. Y., Lin H. C., Lin H. J., Chu C. J., Wu S. L., Tai C. C., Lee S. D. Chronic administration of octreotide ameliorates portal hypertension and portal hypertensive gastropathy in rats with cirrhosis. Clin Sci (Lond) 1998 Apr;94(4):367–371. doi: 10.1042/cs0940367. [DOI] [PubMed] [Google Scholar]
  16. Charneau J., Petit R., Calès P., Dauver A., Boyer J. Antral motility in patients with cirrhosis with or without gastric antral vascular ectasia. Gut. 1995 Oct;37(4):488–492. doi: 10.1136/gut.37.4.488. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Chien C. C., Fang J. T., Huang C. C. Watermelon stomach--an unusual cause of recurrent upper gastrointestinal bleeding in a uremic patient receiving estrogen-progesterone therapy: case report. Changgeng Yi Xue Za Zhi. 1998 Dec;21(4):458–462. [PubMed] [Google Scholar]
  18. El-Newihi H. M., Kanji V. K., Mihas A. A. Activity of gastric mucosal nitric oxide synthase in portal hypertensive gastropathy. Am J Gastroenterol. 1996 Mar;91(3):535–538. [PubMed] [Google Scholar]
  19. Ferraz J. G., Wallace J. L. Underlying mechanisms of portal hypertensive gastropathy. J Clin Gastroenterol. 1997;25 (Suppl 1):S73–S78. doi: 10.1097/00004836-199700001-00012. [DOI] [PubMed] [Google Scholar]
  20. Gostout C. J., Ahlquist D. A., Radford C. M., Viggiano T. R., Bowyer B. A., Balm R. K. Endoscopic laser therapy for watermelon stomach. Gastroenterology. 1989 Jun;96(6):1462–1465. doi: 10.1016/0016-5085(89)90513-1. [DOI] [PubMed] [Google Scholar]
  21. Gostout C. J., Viggiano T. R., Ahlquist D. A., Wang K. K., Larson M. V., Balm R. The clinical and endoscopic spectrum of the watermelon stomach. J Clin Gastroenterol. 1992 Oct;15(3):256–263. doi: 10.1097/00004836-199210000-00019. [DOI] [PubMed] [Google Scholar]
  22. Gostout C. J., Viggiano T. R., Balm R. K. Acute gastrointestinal bleeding from portal hypertensive gastropathy: prevalence and clinical features. Am J Gastroenterol. 1993 Dec;88(12):2030–2033. [PubMed] [Google Scholar]
  23. Gupta R., Saraswat V. A., Kumar M., Naik S. R., Pandey R. Frequency and factors influencing portal hypertensive gastropathy and duodenopathy in cirrhotic portal hypertension. J Gastroenterol Hepatol. 1996 Aug;11(8):728–733. doi: 10.1111/j.1440-1746.1996.tb00322.x. [DOI] [PubMed] [Google Scholar]
  24. Gupta R., Sawant P., Parameshwar R. V., Lele V. R., Kulhalli P. M., Mahajani S. S. Gastric mucosal blood flow and hepatic perfusion index in patients with portal hypertensive gastropathy. J Gastroenterol Hepatol. 1998 Sep;13(9):921–926. doi: 10.1111/j.1440-1746.1998.tb00762.x. [DOI] [PubMed] [Google Scholar]
  25. Hartleb M., Michielsen P. P., Dziurkowska-Marek A. The role of nitric oxide in portal hypertensive systemic and portal vascular pathology. Acta Gastroenterol Belg. 1997 Jul-Sep;60(3):222–232. [PubMed] [Google Scholar]
  26. Henry D. A., O'Connell D. L. Effects of fibrinolytic inhibitors on mortality from upper gastrointestinal haemorrhage. BMJ. 1989 Apr 29;298(6681):1142–1146. doi: 10.1136/bmj.298.6681.1142. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Herman B. E., Vargo J. J., Baum S., Silverman E. D., Eisold J. Gastric antral vascular ectasia: a case report and review of the literature. J Nucl Med. 1996 May;37(5):854–856. [PubMed] [Google Scholar]
  28. Hirao T., Ko S., Kanehiro H., Kakajima Y., Nakano H., Kikuchi E., Matsumura M., Fukui H., Tsujii T. Radical esophagogastrectomy for unshuntable extrahepatic portal hypertension with bleeding varices: report of a case. Surg Today. 1997;27(3):243–246. doi: 10.1007/BF00941653. [DOI] [PubMed] [Google Scholar]
  29. Hosking S. W., Kennedy H. J., Seddon I., Triger D. R. The role of propranolol in congestive gastropathy of portal hypertension. Hepatology. 1987 May-Jun;7(3):437–441. doi: 10.1002/hep.1840070304. [DOI] [PubMed] [Google Scholar]
  30. Hou M. C., Lin H. C., Chen C. H., Kuo B. I., Perng C. L., Lee F. Y., Lee S. D. Changes in portal hypertensive gastropathy after endoscopic variceal sclerotherapy or ligation: an endoscopic observation. Gastrointest Endosc. 1995 Aug;42(2):139–144. doi: 10.1016/s0016-5107(95)70070-6. [DOI] [PubMed] [Google Scholar]
  31. Iwao T., Toyonaga A., Ikegami M., Oho K., Sumino M., Harada H., Sakaki M., Shigemori H., Aoki T., Tanikawa K. Reduced gastric mucosal blood flow in patients with portal-hypertensive gastropathy. Hepatology. 1993 Jul;18(1):36–40. [PubMed] [Google Scholar]
  32. Iwao T., Toyonaga A., Shigemori H., Oho K., Sumino M., Sato M., Tanikawa K. Vasopressin plus oxygen vs vasopressin alone in cirrhotic patients with portal-hypertensive gastropathy: effects on gastric mucosal haemodynamics and oxygenation. J Gastroenterol Hepatol. 1996 Mar;11(3):216–222. doi: 10.1111/j.1440-1746.1996.tb00065.x. [DOI] [PubMed] [Google Scholar]
  33. Jabbari M., Cherry R., Lough J. O., Daly D. S., Kinnear D. G., Goresky C. A. Gastric antral vascular ectasia: the watermelon stomach. Gastroenterology. 1984 Nov;87(5):1165–1170. [PubMed] [Google Scholar]
  34. Jouanolle H., Bretagne J. F., Ramée M. P., Lancien G., Le Jean-Colin I., Heresbach D., Bousser A. M., Chevrant-Breton J., Joram F., Gastard J. Ectasie vasculaire antrale et sclérodermie. Aspects endoscopiques, radiologiques et anatomopathologiques d'une association originale. Gastroenterol Clin Biol. 1989;13(2):217–221. [PubMed] [Google Scholar]
  35. Kamath P. S., Lacerda M., Ahlquist D. A., McKusick M. A., Andrews J. C., Nagorney D. A. Gastric mucosal responses to intrahepatic portosystemic shunting in patients with cirrhosis. Gastroenterology. 2000 May;118(5):905–911. doi: 10.1016/s0016-5085(00)70176-4. [DOI] [PubMed] [Google Scholar]
  36. Kaviani A., Ohta M., Itani R., Sander F., Tarnawski A. S., Sarfeh I. J. Tumor necrosis factor-alpha regulates inducible nitric oxide synthase gene expression in the portal hypertensive gastric mucosa of the rat. J Gastrointest Surg. 1997 Jul-Aug;1(4):371–376. doi: 10.1016/s1091-255x(97)80059-5. [DOI] [PubMed] [Google Scholar]
  37. Kouroumalis E. A., Koutroubakis I. E., Manousos O. N. Somatostatin for acute severe bleeding from portal hypertensive gastropathy. Eur J Gastroenterol Hepatol. 1998 Jun;10(6):509–512. doi: 10.1097/00042737-199806000-00013. [DOI] [PubMed] [Google Scholar]
  38. Kruger R., Ryan M. E., Dickson K. B., Nunez J. F. Diffuse vascular ectasia of the gastric antrum. Am J Gastroenterol. 1987 May;82(5):421–426. [PubMed] [Google Scholar]
  39. Lee F. Y., Wang S. S., Tsai Y. T., Lin H. J., Lin H. C., Chu C. J., Wu S. L., Tai C. C., Lee S. D. Aminoguanidine corrects hyperdynamic circulation without ameliorating portal hypertension and portal hypertensive gastropathy in anesthetized portal hypertensive rats. J Hepatol. 1997 Mar;26(3):687–693. doi: 10.1016/s0168-8278(97)80436-9. [DOI] [PubMed] [Google Scholar]
  40. Li M. K., Sung J. J., Woo K. S., Sanderson J., Leung N. W., Yu L. M., Tsui C. P., Chung S. C., Leung F. W. Somatostatin reduces gastric mucosal blood flow in patients with portal hypertensive gastropathy: a randomized, double-blind crossover study. Dig Dis Sci. 1996 Dec;41(12):2440–2446. doi: 10.1007/BF02100140. [DOI] [PubMed] [Google Scholar]
  41. Liberski S. M., McGarrity T. J., Hartle R. J., Varano V., Reynolds D. The watermelon stomach: long-term outcome in patients treated with Nd:YAG laser therapy. Gastrointest Endosc. 1994 Sep-Oct;40(5):584–587. doi: 10.1016/s0016-5107(94)70258-6. [DOI] [PubMed] [Google Scholar]
  42. Lingenfelser T., Mueller M., Marks I. N., Dette S., Wehrman M., Scheurlen M. Endoscopic laser therapy in a case of gastric antral vascular ectasia (watermelon stomach). Z Gastroenterol. 1993 May;31(5):322–324. [PubMed] [Google Scholar]
  43. Lopez-Talavera J. C., Cadelina G., Olchowski J., Merrill W., Groszmann R. J. Thalidomide inhibits tumor necrosis factor alpha, decreases nitric oxide synthesis, and ameliorates the hyperdynamic circulatory syndrome in portal-hypertensive rats. Hepatology. 1996 Jun;23(6):1616–1621. doi: 10.1002/hep.510230644. [DOI] [PubMed] [Google Scholar]
  44. Lowes J. R., Rode J. Neuroendocrine cell proliferations in gastric antral vascular ectasia. Gastroenterology. 1989 Jul;97(1):207–212. doi: 10.1016/0016-5085(89)91437-6. [DOI] [PubMed] [Google Scholar]
  45. Manning R. J. Estrogen/progesterone treatment of diffuse antral vascular ectasia. Am J Gastroenterol. 1995 Jan;90(1):154–156. [PubMed] [Google Scholar]
  46. McCormick P. A., Ooi H., Crosbie O. Tranexamic acid for severe bleeding gastric antral vascular ectasia in cirrhosis. Gut. 1998 May;42(5):750–752. doi: 10.1136/gut.42.5.750. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Moss S. F., Ghosh P., Thomas D. M., Jackson J. E., Calam J. Gastric antral vascular ectasia: maintenance treatment with oestrogen-progesterone. Gut. 1992 May;33(5):715–717. doi: 10.1136/gut.33.5.715. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Murphy F. T., Enzenauer R. J., Cheney C. P. Watermelon stomach. Arthritis Rheum. 1999 Mar;42(3):573–573. [PubMed] [Google Scholar]
  49. Muñoz J., Albillos A., Pérez-Páramo M., Rossi I., Alvarez-Mon M. Factors mediating the hemodynamic effects of tumor necrosis factor-alpha in portal hypertensive rats. Am J Physiol. 1999 Mar;276(3 Pt 1):G687–G693. doi: 10.1152/ajpgi.1999.276.3.G687. [DOI] [PubMed] [Google Scholar]
  50. Nardone G., Rocco A., Balzano T., Budillon G. The efficacy of octreotide therapy in chronic bleeding due to vascular abnormalities of the gastrointestinal tract. Aliment Pharmacol Ther. 1999 Nov;13(11):1429–1436. doi: 10.1046/j.1365-2036.1999.00647.x. [DOI] [PubMed] [Google Scholar]
  51. Nomura H., Miyake K., Hirakata R., Migita S., Okamoto O., Shiraishi G. Rebamipide prevents occurrence of gastric lesions following transcatheter arterial embolization in the hepatic artery. J Gastroenterol Hepatol. 1999 May;14(5):495–499. doi: 10.1046/j.1440-1746.1999.01889.x. [DOI] [PubMed] [Google Scholar]
  52. Ohta M., Hashizume M., Higashi H., Ueno K., Tomikawa M., Kishihara F., Kawanaka H., Tanoue K., Sugimachi K. Portal and gastric mucosal hemodynamics in cirrhotic patients with portal-hypertensive gastropathy. Hepatology. 1994 Dec;20(6):1432–1436. doi: 10.1002/hep.1840200609. [DOI] [PubMed] [Google Scholar]
  53. Ohta M., Tarnawski A. S., Itani R., Pai R., Tomikawa M., Sugimachi K., Sarfeh I. J. Tumor necrosis factor alpha regulates nitric oxide synthase expression in portal hypertensive gastric mucosa of rats. Hepatology. 1998 Apr;27(4):906–913. doi: 10.1002/hep.510270403. [DOI] [PubMed] [Google Scholar]
  54. Orloff M. J., Orloff M. S., Orloff S. L., Haynes K. S. Treatment of bleeding from portal hypertensive gastropathy by portacaval shunt. Hepatology. 1995 Apr;21(4):1011–1017. [PubMed] [Google Scholar]
  55. Panés J., Bordas J. M., Piqué J. M., Bosch J., García-Pagán J. C., Feu F., Casadevall M., Terés J., Rodés J. Increased gastric mucosal perfusion in cirrhotic patients with portal hypertensive gastropathy. Gastroenterology. 1992 Dec;103(6):1875–1882. doi: 10.1016/0016-5085(92)91447-c. [DOI] [PubMed] [Google Scholar]
  56. Panés J., Bordas J. M., Piqué J. M., García-Pagán J. C., Feu F., Terés J., Bosch J., Rodés J. Effects of propranolol on gastric mucosal perfusion in cirrhotic patients with portal hypertensive gastropathy. Hepatology. 1993 Feb;17(2):213–218. doi: 10.1002/hep.1840170209. [DOI] [PubMed] [Google Scholar]
  57. Panés J., Casadevall M., Fernández M., Piqué J. M., Bosch J., Casamitjana R., Cirera I., Bombí J. A., Terés J., Rodés J. Gastric microcirculatory changes of portal-hypertensive rats can be attenuated by long-term estrogen-progestagen treatment. Hepatology. 1994 Nov;20(5):1261–1270. doi: 10.1002/hep.1840200525. [DOI] [PubMed] [Google Scholar]
  58. Panés J., Piqué J. M., Bordas J. M., Casadevall M., Terés J., Bosch J., Rodés J. Effect of bolus injection and continuous infusion of somatostatin on gastric perfusion in cirrhotic patients with portal-hypertensive gastropathy. Hepatology. 1994 Aug;20(2):336–341. [PubMed] [Google Scholar]
  59. Panés J., Piqué J. M., Bordas J. M., Llach J., Bosch J., Terés J., Rodés J. Reduction of gastric hyperemia by glypressin and vasopressin administration in cirrhotic patients with portal hypertensive gastropathy. Hepatology. 1994 Jan;19(1):55–60. doi: 10.1002/hep.1840190110. [DOI] [PubMed] [Google Scholar]
  60. Park R. H., Danesh B. J., Upadhyay R., Howatson A. G., Lee F. D., Russell R. I. Gastric antral vascular ectasia (watermelon stomach)--therapeutic options. Postgrad Med J. 1990 Sep;66(779):720–723. doi: 10.1136/pgmj.66.779.720. [DOI] [PMC free article] [PubMed] [Google Scholar]
  61. Payen J. L., Cales P., Pienkowski P., Sozzani P., Kervran A., Frexinos J., Pascal J. P. Weakness of mucosal barrier in portal hypertensive gastropathy of alcoholic cirrhosis. Effects of propranolol and enprostil. J Hepatol. 1995 Dec;23(6):689–696. doi: 10.1016/0168-8278(95)80035-2. [DOI] [PubMed] [Google Scholar]
  62. Payen J. L., Calès P. Modifications gastriques au cours de la cirrhose. Gastroenterol Clin Biol. 1991;15(4):285–295. [PubMed] [Google Scholar]
  63. Payen J. L., Calès P., Voigt J. J., Barbe S., Pilette C., Dubuisson L., Desmorat H., Vinel J. P., Kervran A., Chayvialle J. A. Severe portal hypertensive gastropathy and antral vascular ectasia are distinct entities in patients with cirrhosis. Gastroenterology. 1995 Jan;108(1):138–144. doi: 10.1016/0016-5085(95)90018-7. [DOI] [PubMed] [Google Scholar]
  64. Piasecki C., Chin J., Greenslade L., McIntyre N., Burroughs A. K., McCormick P. A. Endoscopic detection of ischaemia with a new probe indicates low oxygenation of gastric epithelium in portal hypertensive gastropathy. Gut. 1995 May;36(5):654–656. doi: 10.1136/gut.36.5.654. [DOI] [PMC free article] [PubMed] [Google Scholar]
  65. Piqué J. M. Portal Hypertensive gastropathy. Baillieres Clin Gastroenterol. 1997 Jun;11(2):257–270. doi: 10.1016/s0950-3528(97)90039-7. [DOI] [PubMed] [Google Scholar]
  66. Potamiano S., Carter C. R., Anderson J. R. Endoscopic laser treatment of diffuse gastric antral vascular ectasia. Gut. 1994 Apr;35(4):461–463. doi: 10.1136/gut.35.4.461. [DOI] [PMC free article] [PubMed] [Google Scholar]
  67. Primignani M., Carpinelli L., Preatoni P., Battaglia G., Carta A., Prada A., Cestari R., Angeli P., Gatta A., Rossi A. Natural history of portal hypertensive gastropathy in patients with liver cirrhosis. The New Italian Endoscopic Club for the study and treatment of esophageal varices (NIEC). Gastroenterology. 2000 Jul;119(1):181–187. doi: 10.1053/gast.2000.8555. [DOI] [PubMed] [Google Scholar]
  68. Pérez-Ayuso R. M., Piqué J. M., Bosch J., Panés J., González A., Pérez R., Rigau J., Quintero E., Valderrama R., Viver J. Propranolol in prevention of recurrent bleeding from severe portal hypertensive gastropathy in cirrhosis. Lancet. 1991 Jun 15;337(8755):1431–1434. doi: 10.1016/0140-6736(91)93125-s. [DOI] [PubMed] [Google Scholar]
  69. Quintero E., Pique J. M., Bombi J. A., Bordas J. M., Sentis J., Elena M., Bosch J., Rodes J. Gastric mucosal vascular ectasias causing bleeding in cirrhosis. A distinct entity associated with hypergastrinemia and low serum levels of pepsinogen I. Gastroenterology. 1987 Nov;93(5):1054–1061. doi: 10.1016/0016-5085(87)90569-5. [DOI] [PubMed] [Google Scholar]
  70. RIDER J. A., KLOTZ A. P., KIRSNER J. B. Gastritis with veno-capillary ectasia as a source of massive gastric hemorrhage. Gastroenterology. 1953 May;24(1):118–123. [PubMed] [Google Scholar]
  71. Romano M., Meise K. S., Suozzo R., Sessa G., Persico M., Coffey R. J. Regional distribution of transforming growth factor-alpha and epidermal growth factor in normal and portal hypertensive gastric mucosa in humans. Dig Dis Sci. 1995 Feb;40(2):263–267. doi: 10.1007/BF02065407. [DOI] [PubMed] [Google Scholar]
  72. Rühl G. H., Schnabel R., Peiseler M., Seidel D. Gastric antral vascular ectasia: a case report of a 10 year follow-up with special consideration of histopathological aspects. Z Gastroenterol. 1994 Mar;32(3):160–164. [PubMed] [Google Scholar]
  73. Sarin S. K., Govil A., Jain A. K., Guptan R. C., Issar S. K., Jain M., Murthy N. S. Prospective randomized trial of endoscopic sclerotherapy versus variceal band ligation for esophageal varices: influence on gastropathy, gastric varices and variceal recurrence. J Hepatol. 1997 Apr;26(4):826–832. doi: 10.1016/s0168-8278(97)80248-6. [DOI] [PubMed] [Google Scholar]
  74. Sarin S. K., Shahi H. M., Jain M., Jain A. K., Issar S. K., Murthy N. S. The natural history of portal hypertensive gastropathy: influence of variceal eradication. Am J Gastroenterol. 2000 Oct;95(10):2888–2893. doi: 10.1111/j.1572-0241.2000.03200.x. [DOI] [PubMed] [Google Scholar]
  75. Sarin S. K., Sreenivas D. V., Lahoti D., Saraya A. Factors influencing development of portal hypertensive gastropathy in patients with portal hypertension. Gastroenterology. 1992 Mar;102(3):994–999. doi: 10.1016/0016-5085(92)90188-5. [DOI] [PubMed] [Google Scholar]
  76. Schoonbroodt D., Horsmans Y., Hoang P., Poncelet-Maton E., Laka A., Geubel A. Anomalies vasculaires gastriques, CREST syndrome et cirrhose biliaire primitive: efficacité de l'association éthinyloestradiol-noréthistérone. Gastroenterol Clin Biol. 1994;18(6-7):649–651. [PubMed] [Google Scholar]
  77. Sezai S., Ito M., Sakurai Y., Kamisaka K., Abe T., Ikegami F., Yamamoto Y., Hirano M. Effects on gastric circulation of treatment for portal hypertension in cirrhosis. Dig Dis Sci. 1998 Jun;43(6):1302–1306. doi: 10.1023/a:1018872227652. [DOI] [PubMed] [Google Scholar]
  78. Shigemori H., Iwao T., Ikegami M., Toyonaga A., Tanikawa K. Effects of propranolol on gastric mucosal perfusion and serum gastrin level in cirrhotic patients with portal hypertensive gastropathy. Dig Dis Sci. 1994 Nov;39(11):2433–2438. doi: 10.1007/BF02087662. [DOI] [PubMed] [Google Scholar]
  79. Soin A. S., Acharya S. K., Mathur M., Sahni P., Nundy S. Portal hypertensive gastropathy in noncirrhotic patients. The effect of lienorenal shunts. J Clin Gastroenterol. 1998 Jan;26(1):64–68. doi: 10.1097/00004836-199801000-00017. [DOI] [PubMed] [Google Scholar]
  80. Spahr L., Villeneuve J. P., Dufresne M. P., Tassé D., Bui B., Willems B., Fenyves D., Pomier-Layrargues G. Gastric antral vascular ectasia in cirrhotic patients: absence of relation with portal hypertension. Gut. 1999 May;44(5):739–742. doi: 10.1136/gut.44.5.739. [DOI] [PMC free article] [PubMed] [Google Scholar]
  81. Sung J. J., Tsui C. P., Li M. K., Leung F. W. Somatostatin attenuates the hyperdynamic circulatory state in the gastric mucosa of rats with portal hypertension. Scand J Gastroenterol. 1995 Sep;30(9):921–926. doi: 10.3109/00365529509101602. [DOI] [PubMed] [Google Scholar]
  82. Tobin R. W., Hackman R. C., Kimmey M. B., Durtschi M. B., Hayashi A., Malik R., McDonald M. F., McDonald G. B. Bleeding from gastric antral vascular ectasia in marrow transplant patients. Gastrointest Endosc. 1996 Sep;44(3):223–229. doi: 10.1016/s0016-5107(96)70155-4. [DOI] [PubMed] [Google Scholar]
  83. Tokushige K., Yamauchi K., Komatsu T., Takasaki K., Hayashi N. Predominant T helper 1 cells in patients with idiopathic portal hypertension. J Gastroenterol Hepatol. 2000 Nov;15(11):1312–1317. [PubMed] [Google Scholar]
  84. Tran A., Villeneuve J. P., Bilodeau M., Willems B., Marleau D., Fenyves D., Parent R., Pomier-Layrargues G. Treatment of chronic bleeding from gastric antral vascular ectasia (GAVE) with estrogen-progesterone in cirrhotic patients: an open pilot study. Am J Gastroenterol. 1999 Oct;94(10):2909–2911. doi: 10.1111/j.1572-0241.1999.01436.x. [DOI] [PubMed] [Google Scholar]
  85. Trevino H. H., Brady C. E., 3rd, Schenker S. Portal hypertensive gastropathy. Dig Dis. 1996 Jul-Aug;14(4):258–270. doi: 10.1159/000171557. [DOI] [PubMed] [Google Scholar]
  86. Tsai H. H., Smith J., Danesh B. J. Successful control of bleeding from gastric antral vascular ectasia (watermelon stomach) by laser photocoagulation. Gut. 1991 Jan;32(1):93–94. doi: 10.1136/gut.32.1.93. [DOI] [PMC free article] [PubMed] [Google Scholar]
  87. Urata J., Yamashita Y., Tsuchigame T., Hatanaka Y., Matsukawa T., Sumi S., Matsuno Y., Takahashi M. The effects of transjugular intrahepatic portosystemic shunt on portal hypertensive gastropathy. J Gastroenterol Hepatol. 1998 Oct;13(10):1061–1067. doi: 10.1111/j.1440-1746.1998.tb00571.x. [DOI] [PubMed] [Google Scholar]
  88. Wang J. Y., Hsieh J. S., Huang T. J. The effect of portal hypertension on transforming growth factor-alpha and epidermal growth factor receptor in the gastric mucosa of rats. Int Surg. 1998 Jul-Sep;83(3):220–223. [PubMed] [Google Scholar]
  89. Weiler H., Weiler C., Gerok W. Gastric mucosal prostaglandin E2 levels in cirrhosis and portal hypertension. J Hepatol. 1990 Jul;11(1):58–64. doi: 10.1016/0168-8278(90)90272-s. [DOI] [PubMed] [Google Scholar]
  90. Woo K. S., Tse L. K., Woo J. L., Vallance-Owen J. Massive pulmonary thromboembolism after tranexamic acid antifibrinolytic therapy. Br J Clin Pract. 1989 Dec;43(12):465–466. [PubMed] [Google Scholar]
  91. Yoshikawa I., Murata I., Nakano S., Otsuki M. Effects of endoscopic variceal ligation on portal hypertensive gastropathy and gastric mucosal blood flow. Am J Gastroenterol. 1998 Jan;93(1):71–74. doi: 10.1111/j.1572-0241.1998.071_c.x. [DOI] [PubMed] [Google Scholar]
  92. Zaman A., Hapke R., Flora K., Rosen H., Benner K. Prevalence of upper and lower gastrointestinal tract findings in liver transplant candidates undergoing screening endoscopic evaluation. Am J Gastroenterol. 1999 Apr;94(4):895–899. doi: 10.1111/j.1572-0241.1999.984_g.x. [DOI] [PubMed] [Google Scholar]
  93. Zoli M., Merkel C., Magalotti D., Marchesini G., Gatta A., Pisi E. Evaluation of a new endoscopic index to predict first bleeding from the upper gastrointestinal tract in patients with cirrhosis. Hepatology. 1996 Nov;24(5):1047–1052. doi: 10.1053/jhep.1996.v24.pm0008903373. [DOI] [PubMed] [Google Scholar]
  94. de la Peña J., Rivero M., Sanchez E., Fábrega E., Crespo J., Pons-Romero F. Variceal ligation compared with endoscopic sclerotherapy for variceal hemorrhage: prospective randomized trial. Gastrointest Endosc. 1999 Apr;49(4 Pt 1):417–423. doi: 10.1016/s0016-5107(99)70036-2. [DOI] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES